MTOR and breast cancer: miR-100 derived from MSCs was shown to decrease expression and protein levels of mTOR, HIF-1α, and VEGF in MDA-MB-231 and MCF-7 breast cancer cell lines (known to overexpress VEGF) when co-cultured with MSCs containing miR-100 (146).